6°Ê888]Ê ÕLiÀÊÓ£ÊUÊiLÀÕ>ÀÞÊÓx]ÊÓä££ N xäZ
Compost plan: neither cheap nor simple Page 3
w w w.PaloA ltoOnline.com
Earthquake faults are closer than you think
page 16 Spectrum 14
Eating Out 29
ShopTalk 30 N Arts
Camp Connection 36
Metamorphosis, children’s theatre-style N Sports Three teams advance in CCSI N Home Rainwater harvesting: nectar from above
Page 23 Page 32 Page 37
womenâ€™s health clinical research
Are You Pursuing Fresh-Cycle In Vitro Fertilization? Hereâ€™s your opportunity to participate in an important clinical research study to evaluate the effectiveness and safety of an investigational long-acting FSH drug (SCH 900962) for ovarian stimulation in women undergoing In-Vitro Fertilization.
General Information Daily subcutaneous injections of FSH are required to achieve sufďŹ cient stimulation of the ovaries during IVF treatment. The long-acting FSH (SCH 900962) used in this research study is an investigational drug designed to remain in the body long enough to stimulate follicle growth for a full week, thereby allowing one injection to replace an entire week of daily injections of FSH.
(FollistimÂŽ). Patients must be undergoing IVF treatment at the Stanford Fertility and Reproductive Medicine Center to participate.
You May Be Eligible If You s !RE BETWEEN THE AGES OF AND s (AVE HAD LESS THAN THREE PRIOR )6&